STAT August 1, 2024
Bob Herman

R1 RCM is finally getting taken off the public markets, ending a months-long saga between private equity firms that were trying to take control of the large health care billing and collections company.

Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are teaming up to buy R1, the companies said Thursday. TowerBrook, in a partnership with the Catholic hospital system Ascension, already owns...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
Cardinal Health set to acquire two companies for combined $3.9B
Cardinal Health inks 2 acquisitions worth $3.9B
VITAS Seeking Large Acquisitions in Hospice CON States
Healthcare & Life Sciences Private Equity Deal Tracker: Vance Street Invests in Prince Sterilization Services

Share This Article